Search by Journal
- HOME
- > Search by Journal
- > International Journal of Myeloma
International Journal of Myeloma
Volume , Issue suppl / 2009
English Article 
Japanese Article- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
|
No hearing Father General running out of riding informs it of a critical situation by the 34th Japan myeloma meeting for the study general meeting team approach in medical care 張高明 International Journal of Myeloma (suppl): 2-2, 2009. |
|---|
|
Current Status and Future Directions of Multiple Myeloma : Perspectives from China Jian Hou International Journal of Myeloma (suppl): 24-25, 2009. |
|---|
|
|
Recent advances in myeloma therapy Brian G.M.Durie International Journal of Myeloma (suppl): 26-26, 2009. |
|---|
|
|
Multi Disciplinary Cancer Treatment for Multiple Myeloma and Management for Side-Effect in the US. Tiffany Richards International Journal of Myeloma (suppl): 28-29, 2009. |
|---|
|
|
The update of novel agents against multiple myeloma : from basic research aspects Teru Hideshima International Journal of Myeloma (suppl): 30-31, 2009. |
|---|
|
|
Efforts of the peripheral neuropathy management in the bortezomib using lecture 1 FACT / GOG-NtxV4.0 三浦比呂子, 津留崎寛子 International Journal of Myeloma (suppl): 32-33, 2009. |
|---|
|
|
About lecture 2 infection measures 川原史子 International Journal of Myeloma (suppl): 34-34, 2009. |
|---|
|
|
Update on Treatment of Multiple Myeloma S.Vincent Rajkumar International Journal of Myeloma (suppl): 36-37, 2009. |
|---|
|
|
Let's survive a critical situation by team approach in medical care 張高明 International Journal of Myeloma (suppl): 41-41, 2009. |
|---|
|
|
About complications and a side effect 村上博和 International Journal of Myeloma (suppl): 42-42, 2009. |
|---|
|
|
Of the bony lesion diagnosis, treatment judging from questionnaire results, actually 和泉透 International Journal of Myeloma (suppl): 43-43, 2009. |
|---|
|
|
Role of a fact and the pharmacist of the side effect management 川原史子 International Journal of Myeloma (suppl): 44-44, 2009. |
|---|
|
|
Role of patients care and the nurse 柏木夕香 International Journal of Myeloma (suppl): 45-45, 2009. |
|---|
|
|
The thing which TERMS aims at 森和彦 International Journal of Myeloma (suppl): 46-46, 2009. |
|---|
|
|
The A-1 marrow interstitial cells reinforces expression of monocytic surface M-CSFR and inhibits the dendritic cells differentiation instruction from a monocyte 日浅雅博1,2, 中野綾子1, 三木浩和1, 原田武志1, 中村信元1, 賀川久美子1, 矢田健一郎1, 尾崎修治3, 安倍正博1, 松本俊夫1 International Journal of Myeloma (suppl): 54-54, 2009. |
|---|
|
|
DCC abnormality of the genes of the A-2 multiple myeloma cell line 名越久朗1, 滝智彦2, 西田一弘1, 後藤美奈子1, 小林覚1, 堤康彦1, 古林勉1, 松本洋典1, 黒田純也1, 堀池重夫1, 大槻剛巳3, 谷脇雅史1,2 International Journal of Myeloma (suppl): 54-54, 2009. |
|---|
|
|
A-3 Pigment Epithelium-Derived Factor inhibits ROS production through the NADPH oxidase activity in myeloma cells 関律子1, 吉田隆文2, 森重聡1, 奥英二郎1, 高田由香1, 今村理恵1, 大崎浩一1, 橋口道俊1, 水野晋一1, 吉本幸冶1, 長藤宏司1, 佐田道夫2, 岡村孝1 International Journal of Myeloma (suppl): 55-55, 2009. |
|---|
|
|
The TRAIL expression of A-4 myeloma cells correlates with a bone allied event 畑裕之, 河野和, 上野志貴子, 菊川佳敬, 奥野豊, 満屋裕明 International Journal of Myeloma (suppl): 55-55, 2009. |
|---|
|
|
The expression of B7-H1 molecules in the A-5 myeloma and participation in condition of a patient 田村秀人1, 山下泰史1, 近藤麻加1, 守屋慶一2, 田野崎栄2, 常理紗1, 檀和夫1, 緒方清行1 International Journal of Myeloma (suppl): 56-56, 2009. |
|---|
|
|
Chromosome 17p13 deletion to become the treatment-resistant index of the A-6 multiple myeloma 板垣允弘, 坂井晃, 木村昭郎 International Journal of Myeloma (suppl): 56-56, 2009. |
|---|
|
|
Examination of the onset in the family of the B-1 multiple myeloma 阿部有, 小倉美津妃, 林さやか, 関根理恵子, 中川靖章, 鈴木憲史 International Journal of Myeloma (suppl): 57-57, 2009. |
|---|
|
|
Examination of the t (4, 14) translocation type multiple myeloma in the B-2 our hospital 中村裕一, 伊藤善啓, 島田恒幸, 脇本直樹, 掛川絵美, 別所正美 International Journal of Myeloma (suppl): 57-57, 2009. |
|---|
|
|
Chromosome aberration and convalescence of the multiple myeloma 146 case in the B-3 our hospital 新井康之, 森田怜子, 前田猛, 上田智朗, 城友泰, 岡田和也, 河田岳人, 伊藤健, 大西達人, 水谷知里, 松山文男, 上田恭典 International Journal of Myeloma (suppl): 58-58, 2009. |
|---|
|
|
Examination of the MGUS inhibitory effect due to the flavonoid Hess Pele Japanese spaniel derived from B-4 citrus fruit 菊川佳敬, 満屋裕明, 畑裕之 International Journal of Myeloma (suppl): 58-58, 2009. |
|---|
|
|
Antitumor effect of Celastrol for B-5 multiple myeloma cells 半田寛1,4, 謝勇1,2, 斉藤貴之3, 小磯博美3, 塚本憲史3, 村上博和1 International Journal of Myeloma (suppl): 59-59, 2009. |
|---|
|
|
Antimyeloma effect through JNK of B-6 humans stabilization Galectin-9 and the p38MAPK course activation 古林勉1, 黒田純也1, 芦原英司2, 照井康仁3, 谷山顕子3, 高木智久4, 足立聡子4, 山本未央1, 畠清彦3, 大水総一6, 山内清明5, 平島光臣6, 谷脇雅史1 International Journal of Myeloma (suppl): 59-59, 2009. |
|---|
|
|
The effectiveness, safe examination of the BD therapy for a recurrence, the intractable myeloma in the C-1 our hospital 稲垣淳1, 飯田真介1, 楠本茂1, 吉田達哉1, 浅尾優1, 小椋啓加1, 森芙美子1, 伊藤旭1, 李政樹1, 石田高司1, 小松弘和1, 上田龍三1 International Journal of Myeloma (suppl): 60-60, 2009. |
|---|
|
|
The effect in the C-2 Bortezomib administration method and examination about the adverse event 木村朗子1, 麻奥英毅2, 許鴻平1, 吉田稚明1, 名越久朗3, 湯浅博美1, 片山雄太1, 岩戸康治4, 許泰一1 International Journal of Myeloma (suppl): 60-60, 2009. |
|---|
|
|
Treatment result of bortezomib for C-3 recurrence, the intractable multiple myeloma 磯田淳1, 馬渡桃子1, 中橋寛隆1, 細川舞2, 眞中章弘3, 星野まち子2, 松本守生1, 澤村守夫1 International Journal of Myeloma (suppl): 61-61, 2009. |
|---|
|
|
Bell Quaid treatment for the myeloma of C-4 Miyazaki 松岡均1,7, 河野浩1,7, 前田宏一2,7, 石崎淳三3,7, 山下清4,7, 河野徳明4,7, 吉田周郎4,7, 佐々木規5,7, 外山孝典5,7, 久冨木庸子6,7, 下田和也6,7 International Journal of Myeloma (suppl): 61-61, 2009. |
|---|
|
|
Look at the multicenter rear in the bortezomib / dexamethasone combination therapy -88 case for the C-5 intractable recurrent multiple myeloma; mark study - 黒田純也1, 古林勉1, 志村和穂1,2, 赤荻照章3, 河田英里3, 上辻由里4, 村頭智5, 初瀬真弓5, 岡野晃5, 岩井俊樹6, 藤本佳子6, 兼子裕人2, 魚嶋伸彦4, 植田豊6, 島崎千尋5, 小林裕3, 堀池重夫1, 谷脇雅史1 International Journal of Myeloma (suppl): 62-62, 2009. |
|---|
|
|
Treatment result of the multiple myeloma that occurred for dialysis-dependent acute renal failure in the D-1 single institution 藤原英晃, 高梨葉子, 岩間幹一, 羽山ブライアン, 山倉昌之, 竹内正美, 末永孝生 International Journal of Myeloma (suppl): 62-62, 2009. |
|---|
|
|
Treatment result of the autologous peripheral blood stem cell transplantation for D-2 primary AL amyloidosis 三木浩和1, 尾崎修治1,2, 賀川久美子1, 竹内恭子1, 原田武志1, 中村信元1, 中野綾子1, 矢田健一郎1, 安倍正博1, 松本俊夫1 International Journal of Myeloma (suppl): 63-63, 2009. |
|---|
|
|
Two cases of the multiple myeloma that showed HBV reactivation in a HBs antigen-negative case before D-3 treatment 吉田達哉1, 楠本茂1, 稲垣淳1, 浅尾優1, 小椋啓加1, 森芙美子1, 伊藤旭1, 李政樹1, 石田高司1, 小松弘和1, 菅内文中2, 田中靖人2, 飯田真介1, 上田龍三1 International Journal of Myeloma (suppl): 63-63, 2009. |
|---|
|
|
Examination about the herpes zoster in D-4 bortezomib patients with treated multiple myeloma 廻勇輔, 黒井大雅, 越智豪, 小西順, 朝倉昇司, 下野玄英, 角南一貴 International Journal of Myeloma (suppl): 64-64, 2009. |
|---|
|
|
Evaluation of the peripheral nerve symptom using the FACT / GOG-Ntx score in the bortezomib treatment of the D-5 multiple myeloma 今村理恵1, 津留崎寛子2, 高橋誠3, 森重聡1, 奥英二郎1, 高田由香1, 大崎浩一1, 関律子1, 橋口道俊1, 薬師寺和昭1, 水野晋一1, 吉本幸治1, 長藤宏司1, 三浦比呂子2, 岡村孝1 International Journal of Myeloma (suppl): 64-64, 2009. |
|---|
|
|
Autologous peripheral blood stem cell transplantation after the E-1 bortezomib + dexamethasone therapy 松本守生1, 磯田淳1, 馬渡桃子1, 中橋寛隆1, 澤村守夫2, 村上博和3 International Journal of Myeloma (suppl): 65-65, 2009. |
|---|
|
|
Examination of the multiple myeloma given the hematopoietic stem cell transplantation that was higher than three times of Hummers 塚本彩人, 北原英晃, 後藤裕樹, 木村悠子, 美山貴彦, 玉井洋太郎, 平井理泉, 谷村聡, 竹下昌孝, 萩原將太郎, 三輪哲義 International Journal of Myeloma (suppl): 65-65, 2009. |
|---|
|
|
Two cases of the multiple myeloma recurrent after the autogenous graft that performed allogeneic mini-transplant after E-3 Bortezomib + Dexamethasone therapy 林敏昭1, 安井寛1, 川上賢太郎1, 池田博1, 高橋文彦2, 西村進3, 石田禎夫1, 今井浩三4, 篠村恭久1 International Journal of Myeloma (suppl): 66-66, 2009. |
|---|
|
|
Four multiple myeloma in acknowledgment of disappearance of the M protein with the E-4 MPT therapy 石山泰二郎1, 佐藤忠嗣2 International Journal of Myeloma (suppl): 66-66, 2009. |
|---|
|
|
Clinical study about the lenalidomide / dexamethasone combination therapy in E-5 recurrence, the intractable Japanese multiple myeloma 永井宏和1, 張高明2, 飯田真介3, 岡本真一郎4, 畠清彦5, 高木敏之6, 清水一之7, 村上博和8, 高徳正昭9, 堀田知光1 International Journal of Myeloma (suppl): 67-67, 2009. |
|---|
|
|
One case of the Velcade, Auto-PBSCT treatment that was effective for Plasmacytoma in the ilium which occurred in F-1 remission Myeloma 林邦雄1, 岡野永求2 International Journal of Myeloma (suppl): 67-67, 2009. |
|---|
|
|
Neutrophilia due to the F-2 G-CSF-producing plasma cell 小磯博美1, 横濱章彦1, 斉藤貴之1, 半田寛2, 塚本憲史1, 唐沢正光3, 島野俊一4, 村上博和2 International Journal of Myeloma (suppl): 68-68, 2009. |
|---|
|
|
The multiple myeloma that left maintenance dialysis by F-3 Bortezomib and Dexamethasone combination therapy 森重聡, 奥英二郎, 高田由香, 関律子, 今村理恵, 大崎浩一, 橋口道俊, 薬師寺和昭, 水野晋一, 吉本幸治, 長藤宏司, 岡村孝 International Journal of Myeloma (suppl): 68-68, 2009. |
|---|
|
|
About clinical pathologic examination of the IgG4 associated diseases that we experienced in F-4 our hospital 斉藤貴之1,2, 杠明憲1, 三井健揮1, 小磯博美1,2, 横濱章彦1, 半田寛3, 塚本憲史1,2, 唐沢正光4, 村上博和3 International Journal of Myeloma (suppl): 69-69, 2009. |
|---|
|
|
One patient whom a diffuse large B-cell lymphoma developed in during treatment of the F-5 multiple myeloma 井上千英子, 野村香織, 池田弘和, 井上信正 International Journal of Myeloma (suppl): 69-69, 2009. |
|---|
|
|
One of the intractable IgE - λ type multiple myeloma that had a diagnosis taking advantage of F-6 cervical spine fractured, and recurred as cardinal symptom for middle water, culf lymphedema after treatment-free climax for two years 華見, 道川尚彦, 萩原政夫 International Journal of Myeloma (suppl): 70-70, 2009. |
|---|
|
|
Examination of the peripheral neuropathy rating system in the G-1 bortezomib administration 細川舞1, 磯田淳2, 眞中章弘3, 馬渡桃子2, 中橋寛隆2, 松本守生2, 星野まち子1, 澤村守夫2 International Journal of Myeloma (suppl): 70-70, 2009. |
|---|
|
|
Efforts of the observation tabulation corresponding to peripheral neuropathy with the treatment of G-2 bell Quaid 斉藤静香, 峯友梢, 吉田佑子, 野上さとみ International Journal of Myeloma (suppl): 71-71, 2009. |
|---|
|
|
The occurrence of adverse event situation with the G-3 bell Quaid therapy is ... through the interview from effect ... patients to give to the life after the discharge 徳田恵, 畑文子, 城内祐美子, 遠藤千賀子, 晝澤征子 International Journal of Myeloma (suppl): 71-71, 2009. |
|---|
|
|
Team approach for the uneasiness of patients with multiple myeloma that shifted to G-4 outpatient department bell Quaid therapy 風間美奈子, 田村千草, 五十嵐聡子, 田澤祐美, 堀富士子 International Journal of Myeloma (suppl): 72-72, 2009. |
|---|
|
|
Outcome improvement of the hematopoietic stem cell transplantation by Multidisciplinary NST for the G-5 multiple myeloma 萩原將太郎1,2, 土屋勇人1, 佐藤ソメヨ1, 綿引美佳1, 望月朋美1, 河内正治1, 三輪哲義2 International Journal of Myeloma (suppl): 72-72, 2009. |
|---|
|
|
Efforts and the evaluation aiming at smooth introduction of the H-1 thalidomide preparation 松井優子, 高堂祥子, 前田冨美子, 石橋律子, 柳原あき子 International Journal of Myeloma (suppl): 73-73, 2009. |
|---|
|
|
Efforts as the present conditions and the pharmacist of formulations of the H-2 thalidomide preparation 久保田美穂1, 緒方正輝1, 中嶋梨紗1, 叶朋子1, 浜辺由紀1, 政賢悟1, 児島強1, 畑裕之2, 齋藤秀之1 International Journal of Myeloma (suppl): 73-73, 2009. |
|---|
|
|
Efforts by the team about the operation of H-3 thalidomide 山口瑞彦1, 吉川圭子2, 水澤裕子2, 中野園子3, 白井直美2, 小野敏明1, 高橋良一3 International Journal of Myeloma (suppl): 74-74, 2009. |
|---|
|
|
Efforts to H-4 multiple myeloma care manual preparation 谷口あゆみ, 安達美樹, 井原国代 International Journal of Myeloma (suppl): 74-74, 2009. |
|---|
|
|
One case of the multiple myeloma that H-5 was at home, and was given medical care at the end of life 佐藤菜穂美1, 山田実穂1, 小久保より子1, 渡部玲子2, 得平道英2, 木崎昌弘2 International Journal of Myeloma (suppl): 75-75, 2009. |
|---|
